============================================================

TABLE 1

============================================================

1.1 — Bivariate Analyses of Covariates Versus Preoperative TMD Status

Table 1.1 Bivariate Analyses of Covariates Versus Preoperative TMD Status
Variable Overall TMD NTMD P-Value (α = 0.05)
Subjects 79 34 45
Age at surgery 0.6653
<20 33 13 20
20-40 43 19 24
>40 3 2 1
Sex 0.4807
Male 27 10 17
Female 52 24 28
Occlusion 0.0057
Class 1 Occlusion 3 1 2
Class 2 Occlusion 29 19 10
Class 3 Occlusion 47 14 33
Surgery 0.3767
BSSO 16 9 7
Le Fort 1 5 2 3
BSSO + Le Fort 1 38 18 20
BSSO + Genioplasty 3 1 2
Le Fort 1 + Genioplasty 0 0 0
BSSO + Le Fort 1 + Genioplasty 17 4 13
Follow Up Time 278 (194, 341) 260 (205, 345) 0.7309
Baseline Axis 2
Baseline PHQ Average 1.83 1.82 1.84 0.97
Baseline JFLS Average 11.82 16.22 8.48 0.0046
Baseline OBC Average 27.59 33.61 22.79 0.0092
Baseline GCPS Average 6.84 9.06 5.23 0.0163

1.2 — Descriptive Univariate Analysis of Preoperative Axis I TMD Subtypes

Descriptive Univariate Analysis of Preoperative Axis I TMD Subtypes
Table 1.2
TMD HA (n) % from TMD Cohort
Myalgia/Local Myalgia 18 52.94%
Myofascial pain +/- Referral 0 0%
Arthralgia 15 44.12%
HTMD 9 26.47%
other 16 47.06%
Intra-Articular (n) % from TMD Cohort
DDWR 19 55.88%
DDWR + Locking 0 0%
DDWOR 5 14.71%
DDWOR + LO 3 8.82%
Other 8 23.53%
DJD (n) % from TMD Cohort
DJD 15 44.12%
Other 19 55.88%

============================================================

TABLE 2

============================================================

2.1 — Axis I Transitions

Table 2.1A
Axis I Transitions in TMD Cohort
Axis 1 Diagnosis Pre-Op TMD Post-Op Resolved (n,%) Post-Op Persistent (n,%) p-value(α = 0.05) FDR adjust p-value(α = 0.05)
Pain-Related TMD & HA
Myalgia 18 14 (77.8%) 4 (22.2%) 0.031 0.056
Local Myalgia 1 1 (100.0%) 0 (0.0%) 1 1
Myofascial Pain with Spreading 0
Myofascial Pain with Referral 0
Arthralgia 15 15 (100.0%) 0 (0.0%) <0.001 <0.001
Headache Attributed to TMD 9 9 (100.0%) 0 (0.0%) 0.004 0.013
Intra-Articular Joint Disorders
DDWR 19 16 (84.2%) 3 (15.8%) 0.004 0.013
DDWR W Intermittent Locking 0
DDWOR with Limited Opening 3 3 (100.0%) 0 (0.0%) 0.25 0.281
DDWOR without Limited Opening 5 5 (100.0%) 0 (0.0%) 0.062 0.09
Other
DJD 15 13 (86.7%) 2 (13.3%) 0.007 0.017
Subluxation 8 1 (12.5%) 7 (87.5%) 0.07 0.09
Table 2.1B
Axis I Transitions in NTMD Cohort
Axis 1 Diagnosis Pre-Op NTMD Post-Op New Onset (n,%) Post-Op Maintained (n,%) p-value(α = 0.05) FDR adjust p-value(α = 0.05)
Pain-Related TMD & HA
Myalgia 37 1 (2.7%) 36 (97.3%) <0.001 <0.001
Local Myalgia 45 0 (0.0%) 45 (100.0%) <0.001 <0.001
Myofascial Pain with Spreading 45 0 (0.0%) 45 (100.0%)
Myofascial Pain with Referral 45 0 (0.0%) 45 (100.0%)
Arthralgia 38 2 (5.3%) 36 (94.7%) <0.001 <0.001
Headache Attributed to TMD 42 2 (4.8%) 40 (95.2%) <0.001 <0.001
Intra-Articular Joint Disorders
DDWR 45 3 (6.7%) 42 (93.3%) <0.001 <0.001
DDWR W Intermittent Locking 45 0 (0.0%) 45 (100.0%)
DDWOR with Limited Opening 45 1 (2.2%) 44 (97.8%) <0.001 <0.001
DDWOR without Limited Opening 45 1 (2.2%) 44 (97.8%) <0.001 <0.001
Other
DJD 44 3 (6.8%) 41 (93.2%) <0.001 <0.001
Subluxation 0

2.2 — Axis II Change

Axis II Change in TMD Cohort
Table 2.2A
Axis II Metric Pre mean (SD) Pre median (IQR) Post mean (SD) Post median (IQR) Mean change Median change p-value (α = 0.05) FDR (α = 0.05)
PHQ-4 (Total) 1.82 (2.49) 1.00 (0.00, 3.00) 1.42 (2.40) 0.00 (0.00, 3.00) -0.39 0 0.384 0.384
OBC 33.61 (25.16) 29.00 (22.00, 37.50) 24.10 (12.02) 23.00 (14.00, 31.00) -9.52 -7 0.023 0.031
JFLS 16.22 (13.07) 15.50 (7.00, 24.25) 5.22 (7.33) 2.50 (0.00, 6.25) -11 -7.5 <0.001 <0.001
GCPS (Total) 9.06 (9.27) 8.00 (0.00, 14.50) 4.10 (6.62) 0.00 (0.00, 5.50) -4.97 -2 0.003 0.007
Axis II Change in NTMD Cohort
Table 2.2B
Axis II Metric Pre mean (SD) Pre median (IQR) Post mean (SD) Post median (IQR) Mean change Median change p-value (α = 0.05) FDR (α = 0.05)
PHQ-4 (Total) 1.84 (2.65) 1.00 (0.00, 2.00) 1.09 (2.23) 0.00 (0.00, 1.00) -0.76 0 0.037 0.037
OBC 22.79 (11.87) 19.00 (17.50, 30.00) 17.33 (9.84) 17.00 (11.50, 21.00) -5.46 -5 0.002 0.007
JFLS 8.48 (11.84) 1.50 (0.00, 15.50) 3.50 (6.03) 0.00 (0.00, 4.00) -4.98 -1 0.004 0.007
GCPS (Total) 5.23 (9.04) 0.00 (0.00, 9.50) 2.37 (5.55) 0.00 (0.00, 3.00) -2.86 0 0.006 0.008
Compare TMD vs NTMD Change
Table 2.2C
Axis II Metric TMD mean change (SD) TMD median change (IQR) NTMD mean change (SD) NTMD median change (IQR) p-value (α = 0.05) Adjusted p-value (α = 0.05) FDR (α = 0.05)
PHQ-4 (Total) -0.39 (2.95) 0.00 (-2.00, 0.00) -0.76 (2.32) 0.00 (-1.00, 0.00) 0.747 0.747 0.747
OBC -9.52 (22.90) -7.00 (-14.00, 0.50) -5.46 (11.38) -5.00 (-8.00, -0.50) 0.53 0.707 0.707
JFLS -11.00 (13.39) -7.50 (-15.75, -1.00) -4.98 (9.97) -1.00 (-7.75, 0.00) 0.03 0.12 0.12
GCPS (Total) -4.97 (8.83) -2.00 (-8.50, 0.00) -2.86 (6.24) 0.00 (-4.00, 0.00) 0.215 0.43 0.43

============================================================

TABLE 3

============================================================

3.1 — Longitudinal Analysis of Subjective Symptom Score Transitions

Table 3.1a
Longitudinal Analysis of Subjective Symptom Score Transitions - TMD Patients
SymptomCluster SQCategory Positive Pre-Op Post-Op Resolved (%) Post-Op Persistent (%) Negative Pre-Op Post-Op New Onset (%) Post-Op Maintained (%) p-value (α = 0.05) FDR adjusted p-value (α = 0.05)
Pain Jaw/Temple/Ear Pain (Q1) 18 3 (16.7%) 15 (83.3%) 4 1 (25.0%) 3 (75.0%) 0.617 0.823
Headache Temple Headaches (Q5) 15 9 (60.0%) 6 (40.0%) 7 0 (0.0%) 7 (100.0%) 0.008 0.031
Joint Noises Joint Noises (Q8) 0
0
Locking Closed Lock (Q9) 9 2 (22.2%) 7 (77.8%) 11 3 (27.3%) 8 (72.7%) 1 1
Open Lock (Q13) 5 5 (100.0%) 0 (0.0%) 15 0 (0.0%) 15 (100.0%) 0.074 0.147
Note: P-values were calculated using McNemar’s test with continuity correction. FDR-adjusted p-values were calculated using the Benjamini-Hochberg method. Statistical significance was defined as α = 0.05.
Table 3.1b
Longitudinal Analysis of Subjective Symptom Score Transitions - NTMD Patients
SymptomCluster SQCategory Positive Pre-Op Post-Op Resolved (%) Post-Op Persistent (%) Negative Pre-Op Post-Op New Onset (%) Post-Op Maintained (%) p-value (α = 0.05) FDR adjusted p-value (α = 0.05)
Pain Jaw/Temple/Ear Pain (Q1) 16 0 (0.0%) 16 (100.0%) 20 0 (0.0%) 20 (100.0%)
Headache Temple Headaches (Q5) 17 9 (52.9%) 8 (47.1%) 18 0 (0.0%) 18 (100.0%) 0.008 0.023
Joint Noises Joint Noises (Q8) 0
0
Locking Closed Lock (Q9) 7 5 (71.4%) 2 (28.6%) 25 3 (12.0%) 22 (88.0%) 0.724 1
Open Lock (Q13) 1 1 (100.0%) 0 (0.0%) 31 0 (0.0%) 31 (100.0%) 1 1
Note: P-values were calculated using McNemar’s test with continuity correction. FDR-adjusted p-values were calculated using the Benjamini-Hochberg method. Statistical significance was defined as α = 0.05.

3.2 — Pre-Op PPV / NPV Analysis

Table 3.2a
Pre Op PPV Analysis for SQ Items - TMD Patients
Symptom Cluster SQ Category Objective Diagnosis (Axis I) Agreement (n,%) Discordance (n,%) PPV (%, 95% CI) p-value(α = 0.05)
Pain Jaw/Temple/Ear Pain (Q1 positive) Myalgia (Including Subtypes) or Arthralgia 18 (66.7%) 9 (33.3%) 66.7% (46.0, 83.5) 0.122
Headache Temple Headaches (Q5) Headache Attributed to TMD 9 (50.0%) 9 (50.0%) 50.0% (26.0, 74.0) 1
Joint Noises Joint Noises (Q8) Disc Displacement Cluster or DJD 23 (95.8%) 1 (4.2%) 95.8% (78.9, 99.9) <0.001
Locking Closed Lock (Q9) Disc Displacement Cluster or DJD 13 (86.7%) 2 (13.3%) 86.7% (59.5, 98.3) 0.007
Open Lock (Q13) Subluxation 0 (0.0%) 5 (100.0%) 0.0% (0.0, 52.2) 0.062
Note: Agreement and discordance are reported as n (%). PPV was calculated as TP / (TP + FP), with 95% confidence intervals from exact binomial tests. Statistical significance was defined as α = 0.05.
Table 3.2b
Pre Op NPV Analysis for SQ Items - NTMD Patients
Symptom Cluster SQ Category Objective Diagnosis (Axis I) Agreement (n,%) Discordance (n,%) NPV (%, 95% CI) p-value(α = 0.05)
Pain Jaw/Temple/Ear Pain (Q1 positive) Other 27 (100.0%) 0 (0.0%) 100.0% (87.2, 100.0) <0.001
Headache Temple Headaches (Q5) Other 24 (100.0%) 0 (0.0%) 100.0% (85.8, 100.0) <0.001
Joint Noises Joint Noises (Q8) Other 29 (100.0%) 0 (0.0%) 100.0% (88.1, 100.0) <0.001
Locking Closed Lock (Q9) Other 32 (100.0%) 0 (0.0%) 100.0% (89.1, 100.0) <0.001
Open Lock (Q13) Other 0 (0.0%) 40 (100.0%) 0.0% (0.0, 8.8) <0.001
Note: Agreement and discordance are reported as n (%). NPV was calculated as TN / (TN + FN), with 95% confidence intervals from exact binomial tests. Statistical significance was defined as α = 0.05.

3.3 — Post-Op PPV / NPV Analysis

Table 3.3a
Post Op PPV Analysis for SQ Items - TMD Patients
Symptom Cluster SQ Category Objective Diagnosis (Axis I) Agreement (TP) (n,%) Discordance (FP) (n,%) PPV (%, 95% CI) p-value (α = 0.05)
Pain Jaw/Temple/Ear Pain (Q1 positive) Myalgia or Arthralgia 9 (64.3%) 5 (35.7%) 64.3% (35.1, 87.2) 0.424
Headache Temple Headaches (Q5) Headache Attributed to TMD 2 (28.6%) 5 (71.4%) 28.6% (3.7, 71.0) 0.453
Joint Noises Joint Noises (Q8) Disc Displacement Cluster or DJD
Locking Closed Lock (Q9) Disc Displacement Cluster or DJD 4 (66.7%) 2 (33.3%) 66.7% (22.3, 95.7) 0.687
Open Lock (Q13) Subluxation
Note: Agreement and discordance are reported as n (%). PPV was calculated as TP / (TP + FP), with 95% confidence intervals from exact binomial tests. Statistical significance was defined as α = 0.05.
Table 3.3b
Post Op NPV Analysis for SQ Items - NTMD Patients
Symptom Cluster SQ Category Objective Diagnosis (Axis I) Agreement (TN) (n,%) Discordance (FN) (n,%) NPV (%, 95% CI) p-value (α = 0.05)
Pain Jaw/Temple/Ear Pain (Q1 positive) Other 20 (100.0%) 0 (0.0%) 100.0% (83.2, 100.0) <0.001
Headache Temple Headaches (Q5) Other 31 (100.0%) 0 (0.0%) 100.0% (88.8, 100.0) <0.001
Joint Noises Joint Noises (Q8) Other
Locking Closed Lock (Q9) Other 29 (100.0%) 0 (0.0%) 100.0% (88.1, 100.0) <0.001
Open Lock (Q13) Other 0 (0.0%) 38 (100.0%) 0.0% (0.0, 9.3) <0.001
Note: Agreement and discordance are reported as n (%). NPV was calculated as TN / (TN + FN), with 95% confidence intervals from exact binomial tests. Statistical significance was defined as α = 0.05.

3.4 — Tables 3.4a/b, 3.5a/b, 3.6a/b, 3.7, 3.8, 3.9

Table 3.4a. Correlation of preoperative subjective symptoms versus objective Axis II scores - TMD patients
Symptom Cluster SQ Category PHQ-4 Anxiety (Median [IQR]) PHQ-4 Depression (Median [IQR]) JFLS Global (Median [IQR]) OBC (Median [IQR]) GCPS Grade (Mode)
Pain Jaw/Temple/Ear Pain (Q1) 0.50 [0.00, 2.00] 0.00 [0.00, 0.75] 16.00 [8.00, 24.00] 30.00 [23.00, 37.00] 1
Headache Temple Headaches (Q5) 2.00 [0.00, 2.00] 0.00 [0.00, 1.00] 18.00 [9.00, 30.00] 30.50 [26.00, 37.75] 3
Joint Noises Joint Noises (Q8) 0.00 [0.00, 2.00] 0.00 [0.00, 0.00] 14.00 [7.00, 18.00] 29.00 [23.25, 34.50] 1
Locking Closed Lock (Q9) 1.00 [0.00, 2.50] 0.00 [0.00, 1.00] 18.00 [13.00, 24.75] 36.00 [27.75, 38.75] 1
Open Lock (Q13) 1.00 [0.00, 2.00] 0.00 [0.00, 0.00] 16.00 [13.00, 30.00] 30.50 [25.00, 35.50] 1
Table 3.4b. Correlation of preoperative subjective symptoms versus objective Axis II scores - NTMD patients
Symptom Cluster SQ Category PHQ-4 Anxiety (Median [IQR]) PHQ-4 Depression (Median [IQR]) JFLS Global (Median [IQR]) OBC (Median [IQR]) GCPS Grade (Mode)
Pain Jaw/Temple/Ear Pain (Q1) 0.00 [0.00, 2.00] 0.00 [0.00, 1.00] 8.00 [3.00, 23.00] 22.50 [18.00, 31.25] 1
Headache Temple Headaches (Q5) 1.00 [0.00, 2.00] 0.00 [0.00, 0.75] 6.00 [1.00, 21.75] 25.00 [21.25, 32.50] 0
Joint Noises Joint Noises (Q8) 0.00 [0.00, 1.00] 0.00 [0.00, 0.00] 3.00 [0.00, 14.50] 31.50 [23.00, 33.50] 0
Locking Closed Lock (Q9) 1.00 [0.00, 1.25] 0.00 [0.00, 0.75] 3.00 [0.00, 14.50] 31.00 [22.00, 32.00] 0
Open Lock (Q13) 2.00 [2.00, 2.00] 3.00 [3.00, 3.00] 35.00 [35.00, 35.00] 40.00 [40.00, 40.00] 1
Table 3.5a. Correlation of postoperative subjective symptoms versus objective Axis II scores - TMD patients
Symptom Cluster SQ Category PHQ-4 Anxiety (Median [IQR]) PHQ-4 Depression (Median [IQR]) JFLS Global (Median [IQR]) OBC (Median [IQR]) GCPS Grade (Mode)
Pain Jaw/Temple/Ear Pain (Q1) 0.00 [0.00, 1.00] 0.00 [0.00, 0.75] 6.50 [3.00, 12.75] 22.50 [18.25, 35.25] 1
Headache Temple Headaches (Q5) 0.00 [0.00, 0.50] 0.00 [0.00, 0.50] 4.00 [2.00, 14.00] 30.00 [24.50, 37.50] 1
Joint Noises Joint Noises (Q8) - - - - -
Locking Closed Lock (Q9) 0.00 [0.00, 0.75] 0.00 [0.00, 0.75] 10.50 [6.25, 18.50] 27.00 [20.25, 35.25] 1
Open Lock (Q13) - - - - -
Table 3.5b. Correlation of postoperative subjective symptoms versus objective Axis II scores - NTMD patients
Symptom Cluster SQ Category PHQ-4 Anxiety (Median [IQR]) PHQ-4 Depression (Median [IQR]) JFLS Global (Median [IQR]) OBC (Median [IQR]) GCPS Grade (Mode)
Pain Jaw/Temple/Ear Pain (Q1) 0.00 [0.00, 2.00] 0.00 [0.00, 1.00] 2.00 [0.00, 11.00] 21.00 [16.00, 24.50] 0
Headache Temple Headaches (Q5) 2.00 [0.00, 3.00] 0.00 [0.00, 2.00] 1.00 [0.00, 3.25] 18.50 [10.25, 27.00] 0
Joint Noises Joint Noises (Q8) - - - - -
Locking Closed Lock (Q9) 0.00 [0.00, 3.00] 0.00 [0.00, 0.00] 2.00 [0.00, 11.00] 23.00 [16.00, 25.00] 1
Open Lock (Q13) - - - - -
Table 3.6a. Pre-op vs post-op PPV analysis for SQ items - TMD patients
Symptom Cluster SQ Category Objective Diagnosis (Axis I) Pre Op PPV (%, 95% CI) Post Op PPV (%, 95% CI)
Pain Jaw/Temple/Ear Pain (Q1 positive) Myalgia (Including Subtypes) or Arthralgia 66.7% (46.0%, 83.5%) 18.8% (4.0%, 45.6%)
Headache Temple Headaches (Q5) Headache Attributed to TMD 50.0% (26.0%, 74.0%) 0.0% (0.0%, 45.9%)
Joint Noises Joint Noises (Q8) Disc Displacement Cluster or DJD 95.8% (78.9%, 99.9%) -
Locking Closed Lock (Q9) Disc Displacement Cluster or DJD 86.7% (59.5%, 98.3%) 30.0% (6.7%, 65.2%)
Open Lock (Q13) Subluxation 0.0% (0.0%, 52.2%) -
Table 3.6b. Pre-op vs post-op NPV analysis for SQ items - NTMD patients
Symptom Cluster SQ Category Objective Diagnosis (Axis I) Pre Op NPV (%, 95% CI) Post Op NPV (%, 95% CI)
Pain Jaw/Temple/Ear Pain (Q1 positive) Other 100.0% (87.2%, 100.0%) 100.0% (83.9%, 100.0%)
Headache Temple Headaches (Q5) Other 100.0% (85.8%, 100.0%) 96.4% (81.7%, 99.9%)
Joint Noises Joint Noises (Q8) Other 100.0% (88.1%, 100.0%) -
Locking Closed Lock (Q9) Other 100.0% (89.1%, 100.0%) 96.7% (82.8%, 99.9%)
Open Lock (Q13) Other 0.0% (0.0%, 8.8%) 8.3% (1.8%, 22.5%)
Table 3.7. Pre-op sensitivity and specificity analysis for SQ items - entire cohort
Symptom Cluster SQ Category Objective Diagnosis (Axis I) n with TMD Diagnosis (TP+FN) Sensitivity (%, 95% CI) p-value Sensitivity n without TMD Diagnosis (FP+TN) Specificity (%, 95% CI) p-value Specificity
Pain Jaw/Temple/Ear Pain (Q1 positive) Myalgia (Including Subtypes) or Arthralgia 28 100.0% (87.7%, 100.0%) <0.001 50 68.0% (53.3%, 80.5%) 0.015
Headache Temple Headaches (Q5) Headache Attributed to TMD 12 100.0% (73.5%, 100.0%) <0.001 63 61.9% (48.8%, 73.9%) 0.077
Joint Noises Joint Noises (Q8) Disc Displacement Cluster or DJD 26 88.5% (69.8%, 97.6%) <0.001 46 71.7% (56.5%, 84.0%) 0.005
Locking Closed Lock (Q9) Disc Displacement Cluster or DJD 28 46.4% (27.5%, 66.1%) 0.851 45 77.8% (62.9%, 88.8%) <0.001
Open Lock (Q13) Subluxation 48 2.1% (0.1%, 11.1%) <0.001 22 77.3% (54.6%, 92.2%) 0.017
Table 3.8. Post-op sensitivity and specificity analysis for SQ items - entire cohort
Symptom Cluster SQ Category Objective Diagnosis (Axis I) n with TMD Diagnosis (TP+FN) Sensitivity (%, 95% CI) p-value Sensitivity n without TMD Diagnosis (FP+TN) Specificity (%, 95% CI) p-value Specificity
Pain Jaw/Temple/Ear Pain (Q1 positive) Myalgia (Including Subtypes) or Arthralgia 9 100.0% (66.4%, 100.0%) 0.004 51 52.9% (38.5%, 67.1%) 0.780
Headache Temple Headaches (Q5) Headache Attributed to TMD 3 66.7% (9.4%, 99.2%) 1.000 57 77.2% (64.2%, 87.3%) <0.001
Joint Noises Joint Noises (Q8) Disc Displacement Cluster or DJD 0 - - 0 - -
Locking Closed Lock (Q9) Disc Displacement Cluster or DJD 11 45.5% (16.7%, 76.6%) 1.000 45 77.8% (62.9%, 88.8%) <0.001
Open Lock (Q13) Subluxation 49 0.0% (0.0%, 7.3%) <0.001 10 100.0% (69.2%, 100.0%) 0.002
Table 3.9. Pre-op vs post-op sensitivity and specificity analysis for SQ items - entire cohort
Symptom Cluster SQ Category Objective Diagnosis (Axis I) Sensitivity Pre-Op Sensitivity Post-Op Specificity Pre-Op Specificity Post-Op
Pain Jaw/Temple/Ear Pain (Q1 positive) Myalgia (Including Subtypes) or Arthralgia 100.0% (87.7%, 100.0%) 100.0% (66.4%, 100.0%) 68.0% (53.3%, 80.5%) 52.9% (38.5%, 67.1%)
Headache Temple Headaches (Q5) Headache Attributed to TMD 100.0% (73.5%, 100.0%) 66.7% (9.4%, 99.2%) 61.9% (48.8%, 73.9%) 77.2% (64.2%, 87.3%)
Joint Noises Joint Noises (Q8) Disc Displacement Cluster or DJD 88.5% (69.8%, 97.6%) - 71.7% (56.5%, 84.0%) -
Locking Closed Lock (Q9) Disc Displacement Cluster or DJD 46.4% (27.5%, 66.1%) 45.5% (16.7%, 76.6%) 77.8% (62.9%, 88.8%) 77.8% (62.9%, 88.8%)
Open Lock (Q13) Subluxation 2.1% (0.1%, 11.1%) 0.0% (0.0%, 7.3%) 77.3% (54.6%, 92.2%) 100.0% (69.2%, 100.0%)

3.4a vs 3.5a — Pre-Op vs Post-Op Axis II Comparison (TMD)

Pre-Op vs. Post-Op Axis II Comparison — TMD Patients (3.4a vs. 3.5a) · Wilcoxon signed-rank
PHQ-4 Anxiety (Median)
PHQ-4 Depression (Median)
JFLS Global (Median)
OBC (Median)
GCPS (Mode)
Symptom Cluster SQ Category Pre-Op Post-Op p-value Pre-Op Post-Op p-value Pre-Op Post-Op p-value Pre-Op Post-Op p-value Pre-Op Post-Op p-value
Pain Jaw/Temple/Ear Pain (Q1) 0.5 0 0.164 0 0 0.776 16 3 30 23 0.031 1 1 0.065
Headache Temple Headaches (Q5) 2 0.5 0.385 0 0 0.666 18 3.5 0.003 30.5 25 0.097 1 1 0.331
Joint Noises Joint Noises (Q8) 0 0 0.166 0 0 0.915 14 3 0.003 29 23 0.06 1 1 0.097
Locking Closed Lock (Q9) 1 0 0.348 0 0 0.583 18 4 0.003 36 24 0.041 1 1 0.212
Open Lock (Q13) 1 2 0.371 0 0 0.371 16 3 0.178 30.5 24 1 1 0 0.345

3.4b vs 3.5b — Pre-Op vs Post-Op Axis II Comparison (NTMD)

Pre-Op vs. Post-Op Axis II Comparison – NTMD Patients (3.4b vs. 3.5b) - Wilcoxon signed-rank
PHQ-4 Anxiety (Median)
PHQ-4 Depression (Median)
JFLS Global (Median)
OBC (Median)
GCPS (Mode)
Symptom Cluster SQ Category Pre-Op Post-Op p-value Pre-Op Post-Op p-value Pre-Op Post-Op p-value Pre-Op Post-Op p-value Pre-Op Post-Op p-value
Pain Jaw/Temple/Ear Pain (Q1) 0 0 0.086 0 0 0.423 8 3 0.016 22.5 19 0.004 1 1 0.327
Headache Temple Headaches (Q5) 1 0 0.17 0 0 0.269 6 2.5 0.007 25 21 0.021 0 1 0.159
Joint Noises Joint Noises (Q8) 0 0 0.168 0 0 0.269 3 3 0.272 31.5 19 0.024 0 0 0.345
Locking Closed Lock (Q9) 1 0 0.371 0 0 1 3 3.5 0.787 31 20 0.059 0 0 1
Open Lock (Q13) 2 2
3 3
35 17 1 40 21 1 4 1 1

3.4a vs 3.4b — Pre-Op: TMD vs NTMD Comparison

Pre-Op Axis II Comparison – TMD vs. NTMD Patients (3.4a vs. 3.4b) · Mann-Whitney U
PHQ-4 Anxiety (Median)
PHQ-4 Depression (Median)
JFLS Global (Median)
OBC (Median)
GCPS (Mode)
Symptom Cluster SQ Category TMD NTMD p-value TMD NTMD p-value TMD NTMD p-value TMD NTMD p-value TMD NTMD p-value
Pain Jaw/Temple/Ear Pain (Q1) 0.5 0 0.578 0 0 0.813 16 8 0.419 30 22.5 0.172 1 1 0.979
Headache Temple Headaches (Q5) 2 1 0.387 0 0 0.983 18 6 0.085 30.5 25 0.172 1 0 0.381
Joint Noises Joint Noises (Q8) 0 0 0.828 0 0 0.819 14 3 0.186 29 31.5 0.919 1 0 0.529
Locking Closed Lock (Q9) 1 1 0.61 0 0 1 18 3 0.04 36 31 0.431 1 0 0.132
Open Lock (Q13) 1 2 0.763 0 3 0.074 16 35 0.373 30.5 40 0.289 1 4 0.289

3.5a vs 3.5b — Post-Op: TMD vs NTMD Comparison

Post-Op Axis II Comparison – TMD vs. NTMD Patients (3.5a vs. 3.5b) · Mann-Whitney U
PHQ-4 Anxiety (Median)
PHQ-4 Depression (Median)
JFLS Global (Median)
OBC (Median)
GCPS (Mode)
Symptom Cluster SQ Category TMD NTMD p-value TMD NTMD p-value TMD NTMD p-value TMD NTMD p-value TMD NTMD p-value
Pain Jaw/Temple/Ear Pain (Q1) 0 0 0.649 0 0 0.889 6.5 2 0.058 22.5 21 0.432 1 1 0.401
Headache Temple Headaches (Q5) 0 2 0.078 0 0 0.58 4 1 0.236 30 18.5 0.056 1 1 0.235
Joint Noises Joint Noises (Q8)
Locking Closed Lock (Q9) 0 0 1 0 0 0.354 10.5 2 0.236 27 23 0.315 1 1 0.259
Open Lock (Q13)

============================================================

TABLE 4

============================================================

Table 4.1 — TMD Cohort: Axis II Improvement Thresholds
Outcome Threshold n Improvement_Percent p_value FDR
Pain Disability Shift to GCPS Grade 0-II 7 71.4 0.453 0.906
Psychosocial Distress PHQ-4 score drop to <= 2 13 46.2 1.000 1.000
Parafunctional Habits OBC score drop to < 25 20 50.0 1.000 1.000
Functional Limitation JFLS score drop to <= 1.74 26 30.8 0.076 0.304
Table 4.2 — NTMD Cohort: Axis II Exacerbation Thresholds
Outcome Threshold n Exacerbation_Percent p_value FDR
Pain Disability Shift to GCPS Grade III-IV 37 0.0
Psychosocial Distress PHQ-4 score increase to >= 3 35 2.9
Parafunctional Habits OBC score increase to >= 25 27 7.4
Functional Limitation JFLS score increase to >= 1.74 21 19.0 0.007 0.007

============================================================

TABLE 5

============================================================

5.1 — TMD Resolution / NTMD New Onset by Covariates

Table 5.1a — TMD Resolution by Covariates
Covariate Level Pre_op_TMD_n Resolved Persistent p_value FDR
Age at surgery 20-40 19 8 (42.1%) 11 (57.9%) 0.034 0.084
Age at surgery <20 13 11 (84.6%) 2 (15.4%)
Age at surgery >40 2 1 (50.0%) 1 (50.0%)
Sex Female 24 11 (45.8%) 13 (54.2%) 0.024 0.084
Sex Male 10 9 (90.0%) 1 (10.0%)
Occlusion Class 1 Occlusion 1 1 (100.0%) 0 (0.0%) 0.055 0.092
Occlusion Class 2 Occlusion 19 8 (42.1%) 11 (57.9%)
Occlusion Class 3 Occlusion 14 11 (78.6%) 3 (21.4%)
Surgery BSSO 9 4 (44.4%) 5 (55.6%) 0.130 0.163
Surgery BSSO + Genioplasty 1 0 (0.0%) 1 (100.0%)
Surgery BSSO + Le Fort 1 18 13 (72.2%) 5 (27.8%)
Surgery BSSO + Le Fort 1 + Genioplasty 4 1 (25.0%) 3 (75.0%)
Surgery Le Fort 1 2 2 (100.0%) 0 (0.0%)
Follow Up Time 6-<12 months 23 12 (52.2%) 11 (47.8%) 0.463 0.463
Follow Up Time <6 months 4 3 (75.0%) 1 (25.0%)
Follow Up Time >=12 months 6 5 (83.3%) 1 (16.7%)
Table 5.1b — NTMD New Onset by Covariates
Covariate Level Pre_op_NTMD_n New_Onset Maintained p_value FDR
Age at surgery 20-40 24 6 (25.0%) 18 (75.0%) 1.000 1.000
Age at surgery <20 20 5 (25.0%) 15 (75.0%)
Age at surgery >40 1 0 (0.0%) 1 (100.0%)
Sex Female 28 9 (32.1%) 19 (67.9%) 0.165 0.412
Sex Male 17 2 (11.8%) 15 (88.2%)
Occlusion Class 1 Occlusion 2 0 (0.0%) 2 (100.0%) 0.017 0.085
Occlusion Class 2 Occlusion 10 6 (60.0%) 4 (40.0%)
Occlusion Class 3 Occlusion 33 5 (15.2%) 28 (84.8%)
Surgery BSSO 7 3 (42.9%) 4 (57.1%) 0.767 0.959
Surgery BSSO + Genioplasty 2 0 (0.0%) 2 (100.0%)
Surgery BSSO + Le Fort 1 20 5 (25.0%) 15 (75.0%)
Surgery BSSO + Le Fort 1 + Genioplasty 13 3 (23.1%) 10 (76.9%)
Surgery Le Fort 1 3 0 (0.0%) 3 (100.0%)
Follow Up Time 6-<12 months 33 8 (24.2%) 25 (75.8%) 0.715 0.959
Follow Up Time <6 months 3 0 (0.0%) 3 (100.0%)
Follow Up Time >=12 months 9 3 (33.3%) 6 (66.7%)

5.2 — Axis II Change by Covariates

Table 5.2a1 — PHQ-4 Change, TMD Cohort
Outcome Cohort Covariate Level n Mean_SD Median_IQR p_value FDR
PHQ-4 TMD Age at surgery 20-40 18 0.17 (3.50) 0.00 (-1.75, 1.75) 0.600 0.600
PHQ-4 TMD Age at surgery <20 13 -0.92 (1.98) 0.00 (-1.00, 0.00)
PHQ-4 TMD Age at surgery >40 2 -2.00 (2.83) -2.00 (-3.00, -1.00)
PHQ-4 TMD Sex Female 23 -0.96 (2.95) 0.00 (-3.50, 0.00) 0.116 0.486
PHQ-4 TMD Sex Male 10 0.90 (2.64) 0.00 (0.00, 0.75)
PHQ-4 TMD Occlusion Class 1 Occlusion 1 -1.00 (NA) -1.00 (-1.00, -1.00) 0.250 0.486
PHQ-4 TMD Occlusion Class 2 Occlusion 18 -1.11 (2.87) 0.00 (-3.50, 0.00)
PHQ-4 TMD Occlusion Class 3 Occlusion 14 0.57 (2.98) 0.00 (0.00, 0.75)
PHQ-4 TMD Surgery BSSO 8 -1.50 (1.77) -1.00 (-2.50, 0.00) 0.291 0.486
PHQ-4 TMD Surgery BSSO + Genioplasty 1 4.00 (NA) 4.00 (4.00, 4.00)
PHQ-4 TMD Surgery BSSO + Le Fort 1 18 0.33 (3.09) 0.00 (-0.75, 0.00)
PHQ-4 TMD Surgery BSSO + Le Fort 1 + Genioplasty 4 -2.25 (3.30) -2.00 (-4.50, 0.25)
PHQ-4 TMD Surgery Le Fort 1 2 -1.00 (2.83) -1.00 (-2.00, 0.00)
PHQ-4 TMD Follow Up Time 6-<12 months 22 -0.64 (2.98) 0.00 (-2.00, 0.00) 0.492 0.600
PHQ-4 TMD Follow Up Time <6 months 4 -0.50 (4.12) 0.00 (-1.50, 1.00)
PHQ-4 TMD Follow Up Time >=12 months 6 0.50 (2.59) 0.00 (0.00, 0.75)
Table 5.2a2 — PHQ-4 Change, NTMD Cohort
Outcome Cohort Covariate Level n Mean_SD Median_IQR p_value FDR
PHQ-4 NTMD Age at surgery 20-40 24 -1.04 (2.27) 0.00 (-1.25, 0.00) 0.423 0.556
PHQ-4 NTMD Age at surgery <20 20 -0.45 (2.44) 0.00 (-1.00, 0.00)
PHQ-4 NTMD Age at surgery >40 1 0.00 (NA) 0.00 (0.00, 0.00)
PHQ-4 NTMD Sex Female 28 -0.54 (2.32) 0.00 (-1.00, 0.00) 0.445 0.556
PHQ-4 NTMD Sex Male 17 -1.12 (2.34) 0.00 (-1.00, 0.00)
PHQ-4 NTMD Occlusion Class 1 Occlusion 2 0.00 (0.00) 0.00 (0.00, 0.00) 0.165 0.412
PHQ-4 NTMD Occlusion Class 2 Occlusion 10 0.40 (2.41) 0.00 (0.00, 2.25)
PHQ-4 NTMD Occlusion Class 3 Occlusion 33 -1.15 (2.27) 0.00 (-1.00, 0.00)
PHQ-4 NTMD Surgery BSSO 7 0.29 (1.70) 0.00 (-0.50, 0.00) 0.133 0.412
PHQ-4 NTMD Surgery BSSO + Genioplasty 2 1.50 (2.12) 1.50 (0.75, 2.25)
PHQ-4 NTMD Surgery BSSO + Le Fort 1 20 -1.30 (2.05) -0.50 (-2.00, 0.00)
PHQ-4 NTMD Surgery BSSO + Le Fort 1 + Genioplasty 13 -1.08 (2.96) 0.00 (-1.00, 0.00)
PHQ-4 NTMD Surgery Le Fort 1 3 0.33 (0.58) 0.00 (0.00, 0.50)
PHQ-4 NTMD Follow Up Time 6-<12 months 33 -0.91 (2.55) 0.00 (-1.00, 0.00) 0.700 0.700
PHQ-4 NTMD Follow Up Time <6 months 3 -0.67 (0.58) -1.00 (-1.00, -0.50)
PHQ-4 NTMD Follow Up Time >=12 months 9 -0.22 (1.72) 0.00 (-1.00, 0.00)
Table 5.2b1 — OBC Change, TMD Cohort
Outcome Cohort Covariate Level n Mean_SD Median_IQR p_value FDR
OBC TMD Age at surgery 20-40 16 -5.56 (17.06) -6.50 (-13.25, 7.50) 0.331 0.414
OBC TMD Age at surgery <20 13 -15.69 (29.55) -8.00 (-16.00, -4.00)
OBC TMD Age at surgery >40 2 -1.00 (0.00) -1.00 (-1.00, -1.00)
OBC TMD Sex Female 22 -8.05 (15.26) -7.00 (-15.00, -1.25) 0.744 0.744
OBC TMD Sex Male 9 -13.11 (36.54) -4.00 (-11.00, 2.00)
OBC TMD Occlusion Class 1 Occlusion 1 19.00 (NA) 19.00 (19.00, 19.00) 0.092 0.414
OBC TMD Occlusion Class 2 Occlusion 18 -5.61 (13.36) -6.50 (-7.75, -1.00)
OBC TMD Occlusion Class 3 Occlusion 12 -17.75 (31.33) -11.50 (-17.00, -1.00)
OBC TMD Surgery BSSO 9 -5.00 (7.68) -7.00 (-7.00, -4.00) 0.234 0.414
OBC TMD Surgery BSSO + Genioplasty 1 -7.00 (NA) -7.00 (-7.00, -7.00)
OBC TMD Surgery BSSO + Le Fort 1 15 -4.13 (14.13) -4.00 (-11.50, 6.00)
OBC TMD Surgery BSSO + Le Fort 1 + Genioplasty 4 -7.75 (21.08) -7.50 (-23.25, 8.00)
OBC TMD Surgery Le Fort 1 2 -75.00 (43.84) -75.00 (-90.50, -59.50)
OBC TMD Follow Up Time 6-<12 months 20 -5.40 (13.68) -6.50 (-11.50, 3.00) 0.289 0.414
OBC TMD Follow Up Time <6 months 4 -8.50 (8.58) -5.50 (-10.50, -3.50)
OBC TMD Follow Up Time >=12 months 6 -27.83 (42.54) -11.50 (-36.00, -8.75)
Table 5.2b2 — OBC Change, NTMD Cohort
Outcome Cohort Covariate Level n Mean_SD Median_IQR p_value FDR
OBC NTMD Age at surgery 20-40 19 -9.68 (12.18) -7.00 (-8.00, -4.00) 0.040 0.201
OBC NTMD Age at surgery <20 19 -1.11 (9.25) -1.00 (-6.00, 4.00)
OBC NTMD Age at surgery >40 1 -8.00 (NA) -8.00 (-8.00, -8.00)
OBC NTMD Sex Female 25 -6.76 (12.89) -5.00 (-8.00, -1.00) 0.355 0.798
OBC NTMD Sex Male 14 -3.14 (7.89) -4.00 (-7.00, 2.00)
OBC NTMD Occlusion Class 1 Occlusion 2 6.50 (16.26) 6.50 (0.75, 12.25) 0.479 0.798
OBC NTMD Occlusion Class 2 Occlusion 7 -6.86 (7.73) -5.00 (-5.50, -3.50)
OBC NTMD Occlusion Class 3 Occlusion 30 -5.93 (11.73) -6.00 (-8.00, 1.50)
OBC NTMD Surgery BSSO 6 -6.33 (5.92) -4.50 (-8.00, -2.50) 0.992 0.992
OBC NTMD Surgery BSSO + Genioplasty 1 -5.00 (NA) -5.00 (-5.00, -5.00)
OBC NTMD Surgery BSSO + Le Fort 1 18 -4.33 (10.05) -6.00 (-8.00, -0.50)
OBC NTMD Surgery BSSO + Le Fort 1 + Genioplasty 11 -7.45 (16.84) -3.00 (-8.00, 2.00)
OBC NTMD Surgery Le Fort 1 3 -3.33 (7.23) -7.00 (-7.50, -1.00)
OBC NTMD Follow Up Time 6-<12 months 27 -5.19 (11.85) -5.00 (-8.00, -1.00) 0.660 0.826
OBC NTMD Follow Up Time <6 months 3 -10.33 (17.67) -19.00 (-20.50, -4.50)
OBC NTMD Follow Up Time >=12 months 9 -4.67 (8.40) -2.00 (-7.00, -1.00)
Table 5.2c1 — JFLS Change, TMD Cohort
Outcome Cohort Covariate Level n Mean_SD Median_IQR p_value FDR
JFLS TMD Age at surgery 20-40 17 -11.94 (15.32) -10.00 (-13.00, -3.00) 0.963 0.963
JFLS TMD Age at surgery <20 13 -10.31 (12.09) -3.00 (-18.00, -1.00)
JFLS TMD Age at surgery >40 2 -7.50 (0.71) -7.50 (-7.75, -7.25)
JFLS TMD Sex Female 23 -13.52 (14.69) -11.00 (-21.50, -2.50) 0.102 0.509
JFLS TMD Sex Male 9 -4.56 (5.98) -3.00 (-8.00, 0.00)
JFLS TMD Occlusion Class 1 Occlusion 1 0.00 (NA) 0.00 (0.00, 0.00) 0.397 0.662
JFLS TMD Occlusion Class 2 Occlusion 18 -8.50 (9.65) -7.50 (-13.00, -1.50)
JFLS TMD Occlusion Class 3 Occlusion 13 -15.31 (17.07) -12.00 (-28.00, -2.00)
JFLS TMD Surgery BSSO 9 -10.33 (12.13) -7.00 (-18.00, -1.00) 0.828 0.963
JFLS TMD Surgery BSSO + Genioplasty 1 -5.00 (NA) -5.00 (-5.00, -5.00)
JFLS TMD Surgery BSSO + Le Fort 1 16 -11.81 (12.02) -10.50 (-15.75, -2.75)
JFLS TMD Surgery BSSO + Le Fort 1 + Genioplasty 4 -4.00 (8.04) -5.50 (-10.25, 0.75)
JFLS TMD Surgery Le Fort 1 2 -24.50 (37.48) -24.50 (-37.75, -11.25)
JFLS TMD Follow Up Time 6-<12 months 22 -9.09 (11.01) -6.00 (-13.75, -2.25) 0.234 0.586
JFLS TMD Follow Up Time <6 months 4 -18.00 (9.27) -15.50 (-21.25, -12.25)
JFLS TMD Follow Up Time >=12 months 6 -13.33 (22.10) -1.00 (-22.75, 0.50)
Table 5.2c2 — JFLS Change, NTMD Cohort
Outcome Cohort Covariate Level n Mean_SD Median_IQR p_value FDR
JFLS NTMD Age at surgery 20-40 21 -2.90 (9.99) 0.00 (-4.00, 0.00) 0.284 0.711
JFLS NTMD Age at surgery <20 20 -7.05 (10.00) -1.50 (-15.00, 0.00)
JFLS NTMD Age at surgery >40 1 -7.00 (NA) -7.00 (-7.00, -7.00)
JFLS NTMD Sex Female 28 -4.93 (10.94) -0.50 (-8.75, 0.00) 0.645 0.806
JFLS NTMD Sex Male 14 -5.07 (8.07) -1.50 (-7.00, 0.00)
JFLS NTMD Occlusion Class 1 Occlusion 2 0.50 (2.12) 0.50 (-0.25, 1.25) 0.427 0.712
JFLS NTMD Occlusion Class 2 Occlusion 10 -3.30 (7.07) 0.00 (-4.00, 0.00)
JFLS NTMD Occlusion Class 3 Occlusion 30 -5.90 (11.00) -1.00 (-14.75, 0.00)
JFLS NTMD Surgery BSSO 7 0.86 (3.93) 0.00 (0.00, 1.50) 0.254 0.711
JFLS NTMD Surgery BSSO + Genioplasty 2 -7.50 (9.19) -7.50 (-10.75, -4.25)
JFLS NTMD Surgery BSSO + Le Fort 1 19 -5.53 (12.20) -1.00 (-12.50, 0.00)
JFLS NTMD Surgery BSSO + Le Fort 1 + Genioplasty 11 -8.00 (9.00) -4.00 (-17.50, 0.00)
JFLS NTMD Surgery Le Fort 1 3 -2.33 (4.04) 0.00 (-3.50, 0.00)
JFLS NTMD Follow Up Time 6-<12 months 30 -4.27 (10.24) -1.00 (-6.50, 0.00) 0.863 0.863
JFLS NTMD Follow Up Time <6 months 3 -10.67 (12.70) -18.00 (-18.00, -7.00)
JFLS NTMD Follow Up Time >=12 months 9 -5.44 (8.66) 0.00 (-7.00, 0.00)
Table 5.2d1 — GCPS Change, TMD Cohort
Outcome Cohort Covariate Level n Mean_SD Median_IQR p_value FDR
GCPS TMD Age at surgery 20-40 17 -4.76 (9.76) -3.00 (-9.00, 0.00) 0.762 0.823
GCPS TMD Age at surgery <20 12 -4.25 (6.68) -1.00 (-6.50, 0.00)
GCPS TMD Age at surgery >40 2 -11.00 (15.56) -11.00 (-16.50, -5.50)
GCPS TMD Sex Female 22 -5.23 (9.47) -2.50 (-10.25, 0.00) 0.582 0.823
GCPS TMD Sex Male 9 -4.33 (7.50) 0.00 (-6.00, 0.00)
GCPS TMD Occlusion Class 1 Occlusion 1 0.00 (NA) 0.00 (0.00, 0.00) 0.783 0.823
GCPS TMD Occlusion Class 2 Occlusion 17 -4.29 (8.17) -4.00 (-8.00, 0.00)
GCPS TMD Occlusion Class 3 Occlusion 13 -6.23 (10.07) 0.00 (-9.00, 0.00)
GCPS TMD Surgery BSSO 8 -2.75 (4.40) -2.00 (-6.50, 0.00) 0.823 0.823
GCPS TMD Surgery BSSO + Genioplasty 1 0.00 (NA) 0.00 (0.00, 0.00)
GCPS TMD Surgery BSSO + Le Fort 1 16 -6.06 (9.26) -4.00 (-12.50, 0.00)
GCPS TMD Surgery BSSO + Le Fort 1 + Genioplasty 4 -1.25 (4.65) -2.00 (-3.75, 0.50)
GCPS TMD Surgery Le Fort 1 2 -15.00 (22.63) -15.00 (-23.00, -7.00)
GCPS TMD Follow Up Time 6-<12 months 22 -3.18 (7.28) -0.50 (-7.50, 0.00) 0.208 0.823
GCPS TMD Follow Up Time <6 months 3 -12.67 (7.64) -11.00 (-16.00, -8.50)
GCPS TMD Follow Up Time >=12 months 6 -7.67 (12.77) -1.50 (-11.25, 0.75)
Table 5.2d2 — GCPS Change, NTMD Cohort
Outcome Cohort Covariate Level n Mean_SD Median_IQR p_value FDR
GCPS NTMD Age at surgery 20-40 22 -1.68 (4.73) 0.00 (-0.75, 0.00) 0.165 0.748
GCPS NTMD Age at surgery <20 20 -3.25 (6.50) 0.00 (-5.00, 0.00)
GCPS NTMD Age at surgery >40 1 -21.00 (NA) -21.00 (-21.00, -21.00)
GCPS NTMD Sex Female 28 -3.57 (7.13) 0.00 (-4.25, 0.00) 0.449 0.748
GCPS NTMD Sex Male 15 -1.53 (4.02) 0.00 (0.00, 0.00)
GCPS NTMD Occlusion Class 1 Occlusion 2 0.00 (0.00) 0.00 (0.00, 0.00) 0.849 0.849
GCPS NTMD Occlusion Class 2 Occlusion 10 -3.10 (6.79) 0.00 (-4.50, 0.00)
GCPS NTMD Occlusion Class 3 Occlusion 31 -2.97 (6.34) 0.00 (-4.00, 0.00)
GCPS NTMD Surgery BSSO 7 -0.57 (2.64) 0.00 (-1.50, 0.50) 0.762 0.849
GCPS NTMD Surgery BSSO + Genioplasty 2 -7.00 (9.90) -7.00 (-10.50, -3.50)
GCPS NTMD Surgery BSSO + Le Fort 1 19 -2.42 (5.81) 0.00 (-2.50, 0.00)
GCPS NTMD Surgery BSSO + Le Fort 1 + Genioplasty 12 -3.17 (6.53) 0.00 (-9.25, 0.00)
GCPS NTMD Surgery Le Fort 1 3 -7.00 (12.12) 0.00 (-10.50, 0.00)
GCPS NTMD Follow Up Time 6-<12 months 31 -1.71 (4.63) 0.00 (-2.50, 0.00) 0.322 0.748
GCPS NTMD Follow Up Time <6 months 3 -7.33 (12.70) 0.00 (-11.00, 0.00)
GCPS NTMD Follow Up Time >=12 months 9 -5.33 (8.02) 0.00 (-8.00, 0.00)